Hypermethylation of the human calcitonin gene as a molecular marker of acute lymphoblastic leukemia

被引:0
作者
Marintich, DV
Uss, AL
Smirnova, LA
Vorobyev, LA
Holmes, JA
Sulimova, GE
Shevchuk, TV
Buryanov, YI
机构
[1] Republican Ctr Transplantat Bone Marrow, Minsk, BELARUS
[2] Byelorussian Med Acad Postgrad Educ, Minsk, BELARUS
[3] Queen Elizabeth Hosp, Dept Transplantat Bone Marrow, Birmingham B15 2TH, W Midlands, England
[4] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 117809, Russia
[5] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Pushchino Brnach, Pushchino 142290, Moscow Oblast, Russia
来源
VOPROSY MEDITSINSKOI KHIMII | 2001年 / 47卷 / 05期
关键词
acute lymphoblastic leukemia; DNA hypermethylation; calcitonin gene; relapse; diagnostics;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HpaII/MspI blot-hybridization analysis of the 5'-end region of the calcitonin (CT) gene methylation in cells of bone marrow and peripheral blood of patients with acute lymphoblastic leukemias (ALL) has been carried out. ALLs are accompanied by hypermethylation of the inner cytosine in the CCGG sequences of this region of the CT gene. The level of hypermethylation of the CT gene corresponded to the degree of disease progression and malignancy. At a long-term remission, hypermethylation of the CT gene is not observed. In case of primary resistance or if the complete remission has not been achived the CT gene remained hypermethylated. It has been shown that in relapse the normal CT gene methylation pattern reversed to hypermethylation. This, phenomenon was detected 1-8 months before the obvious clinical and laboratory signs of the disease progression (relapse). The large size of abnormal HpaII-fragments of the 5'-end region of the calcitonin gene had a direct correlation with the malignancy status of ALL.
引用
收藏
页码:537 / 546
页数:10
相关论文
共 17 条
  • [1] BAYLIN SB, 1986, CANCER RES, V46, P2917
  • [2] BAYLIN SB, 1987, BLOOD, V70, P412
  • [3] Baylin SB, 1998, ADV CANCER RES, V72, P141
  • [4] BELOKHVOSTOV AS, 1999, VOP ONKOL, P599
  • [5] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA - METHODOLOGIC ADVANCES AND CLINICAL-SIGNIFICANCE
    CAMPANA, D
    PUI, CH
    [J]. BLOOD, 1995, 85 (06) : 1416 - 1434
  • [6] THE BIOLOGY AND TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    COPELAN, EA
    MCGUIRE, EA
    [J]. BLOOD, 1995, 85 (05) : 1151 - 1168
  • [7] CYTOGENETICS AND THEIR PROGNOSTIC VALUE IN DENOVO ACUTE MYELOID-LEUKEMIA - A REPORT ON 283 CASES
    FENAUX, P
    PREUDHOMME, C
    LAI, JL
    MOREL, P
    BEUSCART, R
    BAUTERS, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (01) : 61 - 67
  • [8] USE OF THE POLYMERASE CHAIN-REACTION TO DETECT HYPERMETHYLATION IN THE CALCITONIN GENE - A NEW, SENSITIVE APPROACH TO MONITOR TUMOR-CELLS IN ACUTE MYELOGENOUS LEUKEMIA
    FUKUHARA, T
    HOOPER, WC
    BAYLIN, SB
    BENSON, J
    PRUCKLER, J
    OLSON, AC
    EVATT, BL
    VOGLER, WR
    [J]. LEUKEMIA RESEARCH, 1992, 16 (10) : 1031 - 1040
  • [9] INCREASED CYTOSINE DNA-METHYLTRANSFERASE ACTIVITY DURING COLON-CANCER PROGRESSION
    ISSA, JPJ
    VERTINO, PM
    WU, JJ
    SAZAWAL, S
    CELANO, P
    NELKIN, BD
    HAMILTON, SR
    BAYLIN, SB
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (15) : 1235 - 1240
  • [10] A 5-DRUG REMISSION INDUCTION REGIMEN WITH INTENSIVE CONSOLIDATION FOR ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - CANCER AND LEUKEMIA GROUP-B STUDY-8811
    LARSON, RA
    DODGE, RK
    BURNS, CP
    LEE, EJ
    STONE, RM
    SCHULMAN, P
    DUGGAN, D
    DAVEY, FR
    SOBOL, RE
    FRANKEL, SR
    HOOBERMAN, AL
    WESTBROOK, CA
    ARTHUR, DC
    GEORGE, SL
    BLOOMFIELD, CD
    SCHIFFER, CA
    [J]. BLOOD, 1995, 85 (08) : 2025 - 2037